Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Intercure Ltd. (INCR:NASDAQ), powered by AI.
Intercure Ltd. is currently trading at $0.87. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Intercure Ltd. on Alpha Lenz.
View Intercure Ltd.'s valuation metrics on Alpha Lenz.
“Intercure Ltd.'s ROE is -9.0%. Explore profitability and growth together.”
Ask for details →Intercure Ltd. is a leading pharmaceutical company focused on the development, production, and distribution of cannabis-based products. It stands at the forefront of the medical cannabis industry, leveraging advanced cultivation techniques and proprietary R&D to provide high-quality treatments for a range of medical conditions. Intercure's extensive portfolio includes both therapeutic and wellness products designed to meet the needs of patients and healthcare providers. The company is engaged in several strategic partnerships and collaborations with global leaders in the pharmaceutical and wellness sectors, enhancing its market reach and innovation capabilities. Intercure's operations and distribution networks span multiple countries, positioning it as a key player in the rapidly evolving cannabis market. Through its commitment to rigorous scientific research and regulatory compliance, Intercure is instrumental in advancing the acceptance and integration of medical cannabis into mainstream healthcare solutions. Its active participation in clinical studies and contribution to cannabinoid pharmacology underscores its significant role in the field, supporting informed decisions and elevating health outcomes.
“Intercure Ltd.'s ROE is -9.0%. Explore profitability and growth together.”
Ask for details →Intercure Ltd. (ticker: INCR) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 320 employees.
The current price is $0.874 with a P/E ratio of -x and P/B of -x.
ROE is -9.00% and operating margin is 2.49%. Annual revenue is $270M.